Some cancer patients experience a puzzling side effect: difficulty with thinking, memory and focus. Often referred to as “chemo brain” or “brain fog,” this cognitive impairment can impact daily life, making it hard to remember things, concentrate, or complete tasks. Whereas concerning, research suggests a surprising link between cancer and a reduced risk of Alzheimer’s disease, offering a potential new avenue for understanding and potentially combating the neurodegenerative condition.
The changes in cognitive function typically occur before, during, and after cancer treatment, but can also affect individuals who haven’t undergone treatment or are years removed from it. Cancer treatments like chemotherapy, surgery, radiation, immunotherapy, hormone therapy, and targeted drug therapies can all contribute to these cognitive shifts. Other medications used during cancer care, such as steroids, anti-nausea drugs, and pain relievers, may also play a role.
However, the causes of these thinking changes are complex and not fully understood. Factors beyond treatment can also contribute, including the cancer itself – particularly brain tumors – as well as other health conditions like diabetes or high blood pressure. Symptoms of cancer or its treatment, such as fatigue, pain, and sleep disturbances, can exacerbate cognitive difficulties. Stress, anxiety, depression, anemia, hormonal changes (like those experienced during menopause), poor nutrition, older age, and substance use can all increase the risk or worsen existing cognitive impairment.
Importantly, for most people, these thinking changes are not indicative of a more serious condition like Alzheimer’s disease. The cognitive effects often subside over time, but understanding the contributing factors and seeking appropriate support is crucial for managing these challenges. This research highlights the intricate connection between cancer and neurological health, potentially opening doors for new preventative strategies and treatments.
Recent research, as reported by Cerveau &. Psycho on January 26, 2026, suggests that a protein found in tumors may play a role in “cleaning” the brain. This discovery could explain why Alzheimer’s disease appears to be less common in individuals with cancer. The protein, called Cystatin C, is currently being investigated for its potential neuroprotective properties.
Cognitive changes can also manifest as a “mental cloudiness,” a condition increasingly recognized in individuals recovering from illnesses like COVID-19 or experiencing hormonal shifts during menopause, according to reports from March 2026. This broader phenomenon underscores the importance of addressing cognitive health across a range of medical conditions and life stages.
